Radiation Oncology Journal

  • 제33권4호
  • /
  • Pages.328-336
  • /
  • 2015
  • /
  • 2234-1900(pISSN)
  • /
  • 2234-3156(eISSN)
대한방사선종양학회 (The Korean Society for Radiation Oncology)
권호 표지
DOI QR코드

DOI QR Code

Met inactivation by S-allylcysteine suppresses the migration and invasion of nasopharyngeal cancer cells induced by hepatocyte growth factor

  • Cho, Oyeon (Department of Radiation Oncology, Ajou University School of Medicine) ;
  • Hwang, Hye-Sook (Department of Otolaryngology, Ajou University School of Medicine) ;
  • Lee, Bok-Soon (Department of Otolaryngology, Ajou University School of Medicine) ;
  • Oh, Young-Taek (Department of Radiation Oncology, Ajou University School of Medicine) ;
  • Kim, Chul-Ho (Department of Otolaryngology, Ajou University School of Medicine) ;
  • Chun, Mison (Department of Radiation Oncology, Ajou University School of Medicine)
  • 투고 : 2015.07.15
  • 심사 : 2015.08.21
  • 발행 : 2015.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: Past studies have reported that S-allylcysteine (SAC) inhibits the migration and invasion of cancer cells through the restoration of E-cadherin, the reduction of matrix metalloproteinase (MMP) and Slug protein expression, and inhibition of the production of reactive oxygen species (ROS). Furthermore, evidence is emerging that shows that ROS induced by radiation could increase Met activation. Following on these reports of SAC and Met, we investigated whether SAC could suppress Met activation. Materials and Methods: Wound healing, invasion, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium (MTT), soft agar colony forming, western blotting, and gelatin zymography assays were performed in the human nasopharyngeal cancer cell lines HNE1 and HONE1 treated with SAC (0, 10, 20, or 40 mM) and hepatocyte growth factor (HGF). Results: This study showed that SAC could suppress the migration and invasion of HNE1 and HONE1 cell lines by inhibiting p-Met. An increase of migration and invasion induced by HGF and its decrease in a dose dependent manner by SAC in wound healing and invasion assays was observed. The reduction of p-Met by SAC was positively correlated with p-focal adhesion kinase (p-FAK) and p-extracellular related kinase (p-ERK in both cell lines). SAC reduced Slug, MMP2, and MMP9 involved in migration and invasion with the inhibition of Met-FAK signaling. Conclusion: These results suggest that SAC inhibited not only Met activation but also the downstream FAK, Slug, and MMP expression. Finally, SAC may be a potent anticancer compound for nasopharyngeal cancer treated with radiotherapy.

키워드

참고문헌

  1. Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631-7. https://doi.org/10.1200/JCO.2003.06.158
  2. Kim YJ, Lee SH, Wu HG, Go H, Jeon YK. Immunohistochemical study to evaluate the prognostic significance of four biomolecular markers in radiotherapy of nasopharyngeal carcinoma. J Korean Soc Ther Radiol Oncol 2010;28:57-63. https://doi.org/10.3857/jkstro.2010.28.2.57
  3. Luan T, Yu Y. Increased hepatocyte growth factor and c-Met receptor expression in nasopharyngeal carcinoma. Int J Clin Exp Med 2014;7:5583-7.
  4. De Bacco F, Luraghi P, Medico E, et al. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J Natl Cancer Inst 2011;103:645-61. https://doi.org/10.1093/jnci/djr093
  5. Liu T, Li Q, Sun Q, et al. MET inhibitor PHA-665752 suppresses the hepatocyte growth factor-induced cell proliferation and radioresistance in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 2014;449:49-54. https://doi.org/10.1016/j.bbrc.2014.04.147
  6. Colin-Gonzalez AL, Santana RA, Silva-Islas CA, Chanez-Cardenas ME, Santamaria A, Maldonado PD. The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection. Oxid Med Cell Longev 2012;2012:907162.
  7. Chu Q, Lee DT, Tsao SW, Wang X, Wong YC. S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions. BJU Int 2007;99:925-32. https://doi.org/10.1111/j.1464-410X.2006.06639.x
  8. Gapter LA, Yuin OZ, Ng KY. S-Allylcysteine reduces breast tumor cell adhesion and invasion. Biochem Biophys Res Commun 2008;367:446-51. https://doi.org/10.1016/j.bbrc.2007.12.175
  9. Tang FY, Chiang EP, Chung JG, Lee HZ, Hsu CY. S-allylcysteine modulates the expression of E-cadherin and inhibits the malignant progression of human oral cancer. J Nutr Biochem 2009;20:1013-20. https://doi.org/10.1016/j.jnutbio.2008.09.007
  10. Tang FY, Chiang EP, Pai MH. Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model. J Agric Food Chem 2010;58:11156-64. https://doi.org/10.1021/jf102539k
  11. Welch C, Wuarin L, Sidell N. Antiproliferative effect of the garlic compound S-allyl cysteine on human neuroblastoma cells in vitro. Cancer Lett 1992;63:211-9. https://doi.org/10.1016/0304-3835(92)90263-U
  12. Ng KT, Guo DY, Cheng Q, et al. A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma. PLoS One 2012;7:e31655. https://doi.org/10.1371/journal.pone.0031655
  13. Lim YC, Park HY, Hwang HS, et al. (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett 2008;271:140-52. https://doi.org/10.1016/j.canlet.2008.05.048
  14. Qian CN, Guo X, Cao B, et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res 2002;62:589-96.
  15. Organ SL, Tsao MS. An overview of the c-MET signaling pathway. Ther Adv Med Oncol 2011;3:S7-S19. https://doi.org/10.1177/1758834011422556
  16. Eder JP, Vande Woude GF, Boerner SA, LoRusso PM. Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 2009;15:2207-14. https://doi.org/10.1158/1078-0432.CCR-08-1306
  17. Medina-Campos ON, Barrera D, Segoviano-Murillo S, et al. S-allylcysteine scavenges singlet oxygen and hypochlorous acid and protects LLC-PK(1) cells of potassium dichromateinduced toxicity. Food Chem Toxicol 2007;45:2030-9. https://doi.org/10.1016/j.fct.2007.05.002
  18. Chu Q, Ling MT, Feng H, et al. A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression. Carcinogenesis 2006;27:2180-9. https://doi.org/10.1093/carcin/bgl054
  19. Chen SY, Chen HC. Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion. Mol Cell Biol 2006;26:5155-67. https://doi.org/10.1128/MCB.02186-05
  20. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816-26. https://doi.org/10.1038/nrm1490
  21. Zhang K, Chen D, Jiao X, et al. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Lab Invest 2011;91:426-38. https://doi.org/10.1038/labinvest.2010.201
  22. Sivertsen S, Hadar R, Elloul S, et al. Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression. Lung Cancer 2006;54:309-17. https://doi.org/10.1016/j.lungcan.2006.08.010
  23. Lee BS, Kang S, Kim KA, et al. Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression. Cell Death Dis 2014;5:e1159. https://doi.org/10.1038/cddis.2014.119
  24. Ferraro D, Corso S, Fasano E, et al. Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene 2006;25:3689-98. https://doi.org/10.1038/sj.onc.1209409
  25. Jagadeeswaran R, Jagadeeswaran S, Bindokas VP, Salgia R. Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells. Am J Physiol Lung Cell Mol Physiol 2007;292: L1488-94. https://doi.org/10.1152/ajplung.00147.2006

피인용 문헌

  1. Recent Development of Hydrogen Sulfide Releasing/Stimulating Reagents and Their Potential Applications in Cancer and Glycometabolic Disorders vol.8, pp.None, 2017, https://doi.org/10.3389/fphar.2017.00664
  2. C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I vol.13, pp.5, 2015, https://doi.org/10.3892/etm.2017.4249
  3. Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism vol.10, pp.1, 2017, https://doi.org/10.1186/s13045-016-0387-6
  4. Recent progress in natural dietary non-phenolic bioactives on cancers metastasis vol.26, pp.3, 2015, https://doi.org/10.1016/j.jfda.2018.05.003
  5. The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma vol.25, pp.10, 2015, https://doi.org/10.3390/molecules25102454